Stay updated on CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.

Latest updates to the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page
- CheckyesterdayChange DetectedAdded a recruitment status update indicating no longer looking for participants, and introduced several help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). Updated header text for Intervention/Treatment and revised the site revision tag from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check8 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a new version of the page.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a new version of the page. This update is at the metadata level and does not modify the study details or user-facing content.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.0 to v3.5.3, reflecting a site release rather than a change to the clinical trial information.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded Squamous cell carcinoma of the head and neck to the conditions and included the Genetic and Rare Diseases Information Center as a new resource.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.